Virtus Family Office’s Gilead Sciences GILD Stock Holding History

Virtus Family Office’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$852K	Sell	6,114 -720	-11%	-$101K	0.73%	42
2025 Q4	$839K	Buy	+6,834	New	+$831K	0.72%	40
2024 Q4	–	Sell	-27,183	Closed	-$2.28M	–	43
2024 Q3	$2.28M	Sell	27,183 -232	-0.8%	-$17.7K	3.01%	11
2024 Q2	$1.88M	Buy	27,415 +5,439	+25%	+$363K	2.56%	14
2024 Q1	$1.61M	Hold	21,976	–	–	2.57%	18
2023 Q4	$1.78M	Buy	21,976 +856	+4%	+$66.6K	2.98%	17
2023 Q3	$1.58M	Buy	21,120 +2,929	+16%	+$225K	2.87%	14
2023 Q2	$1.4M	Buy	18,191 +2,169	+14%	+$173K	2.6%	16
2023 Q1	$1.33M	Hold	16,022	–	–	2.62%	14
2022 Q4	$1.38M	Buy	16,022 +830	+5%	+$65.7K	3.07%	10
2022 Q3	$937K	Buy	+15,192	New	+$958K	2.39%	13

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Virtus Family Office's GILD Position: Q1 2026 in Review

Virtus Family Office reduced its Gilead Sciences (GILD) stake by 11% in Q1 2026, selling an estimated $101K and leaving 6,114 shares worth $852K. The position accounts for 0.73% of the portfolio, ranked #42.

Virtus Family Office first reported a position in GILD in Q3 2022 and has held it in 11 quarters since. The position peaked at $2.28M in Q3 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Virtus Family Office held 6,114 shares of Gilead Sciences worth $852K as of Q1 2026.
Virtus Family Office sold 720 Gilead Sciences shares in Q1 2026, an estimated $101K.
Gilead Sciences made up 0.73% of Virtus Family Office's portfolio in Q1 2026, its #42 holding.
Virtus Family Office first reported a position in Gilead Sciences in Q3 2022 and has held it in 11 quarters since.
Virtus Family Office's Gilead Sciences position peaked at $2.28M in Q3 2024.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Virtus Family Office's 13F filing for Q1 2026, filed 7 May 2026.